The truncated 23-230 form of the prion protein localizes to the nuclei of inducible cell lines independently of its nuclear localization signals and is not cytotoxic

Molecular and Cellular Neuroscience

Volumn 32, Issue 4, 2006, Pages 315-323

  Crozet, Carole ^a   Vézilier, Julien ^a   Delfieu, Virginie ^a   Nishimura, Takuya ^b   Onodera, Takashi ^b   Casanova, Danielle ^a   Lehmann, Sylvain ^a   Béranger, Florence ^a  

^a INSTITUTE OF HUMAN GENETICS   (France)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL DISRUPTION; CELL NUCLEUS; CELL VIABILITY; CELLULAR DISTRIBUTION; CHROMATIN; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; EMBRYO; HIPPOCAMPUS; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; COLCHICINE; DOXYCYCLINE; EMBRYO; GENE EXPRESSION; HIPPOCAMPUS; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; NEUROBLASTOMA; NEURONS; NUCLEAR LOCALIZATION SIGNALS; PEPTIDE FRAGMENTS; PRIONS; TRANSDUCTION, GENETIC;

MUS MUSCULUS;

EID: 33746770348     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2006.05.004     Document Type: Article

References (35)

1. Aplin A.E., and Juliano R.L. Regulation of nucleocytoplasmic trafficking by cell adhesion receptors and the cytoskeleton. J. Cell Biol. 155 (2001) 187-191
2. Basler K., Oesch B., Scott M., Westaway D., Walchli M., Groth D.F., McKinley M.P., Prusiner S.B., and Weissmann C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46 (1986) 417-428
3. Beranger F., Mange A., Goud B., and Lehmann S. Stimulation of PrPc retrograde transport toward the endoplasmic reticulum increases accumulation of PrPSc in prion-infected cells. J. Biol. Chem. 277 (2002) 38972-38977
4. Blencowe B.J., Nickerson J.A., Issner R., Penman S., and Sharp P.A. Association of nuclear matrix antigens with exon-containing splicing complexes. J. Cell Biol. 127 (1994) 593-607
5. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., and Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
6. Campbell E.M., and Hope T.J. Role of the cytoskeleton in nuclear import. Adv. Drug Delivery Rev. 55 (2003) 761-771
7. Cepko C.L. Immortalization of neural cells via retrovirus-mediated oncogene transduction. Annu. Rev. Neurosci. 12 (1989) 47-65
8. Copani A., Uberti D., Sortino M.A., Bruno V., Nicoletti F., and Memo M. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path?. Trends Neurosci. 24 (2001) 25-31
9. Cordeiro Y., Machado F., Juliano L., Juliano M.A., Brentani R.R., Foguel D., and Silva J.L. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation. J. Biol. Chem. 276 (2001) 49400-49409
10. Drisaldi B., Stewart R.S., Adles C., Stewart L.R., Quaglio E., Biasini E., Fioriti L., Chiesa R., and Harris D.A. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem. 278 (2003) 21732-21743
11. Fioriti L., Dossena S., Stewart L.R., Stewart R.S., Harris D.A., Forloni G., and Chiesa R. Cytosolic prion protein PrP is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J. Biol. Chem. 280 (2005) 11320-11328
12. Gabus C., Auxilien S., Pechoux C., Dormont D., Swietnicki W., Morillas M., Surewicz W., Nandi P., and Darlix J.L. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J. Mol. Biol. 307 (2001) 1011-1021
13. Gabus C., Derrington E., Leblanc P., Chnaiderman J., Dormont D., Swietnicki W., Morillas M., Surewicz W.K., Marc D., Nandi P., et al. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J. Biol. Chem. 276 (2001) 19301-19309
14. Gage F.H., Ray J., and Fisher L.J. Isolation, characterization, and use of stem cells from the CNS. Annu. Rev. Neurosci. 18 (1995) 159-192
15. Giannakakou P., Sackett D.L., Ward Y., Webster K.R., Blagosklonny M.V., and Fojo T. p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat. Cell Biol. 2 (2000) 709-717
16. Gu Y., Hinnerwisch J., Fredricks R., Kalepu S., Mishra R.S., and Singh N. Identification of cryptic nuclear localization signals in the prion protein. Neurobiol. Dis. 12 (2003) 133-149
17. Hsiao K.K., Groth D., Scott M., Yang S.L., Serban H., Rapp D., Foster D., Torchia M., Dearmond S.J., and Prusiner S.B. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9126-9130
18. Jaegly A., Mouthon F., Peyrin J.M., Camugli B., Deslys J.P., and Dormont D. Search for a nuclear localization signal in the prion protein. Mol. Cell. Neurosci. 11 (1998) 127-133
19. Lam M.H., Thomas R.J., Loveland K.L., Schilders S., Gu M., Martin T.J., Gillespie M.T., and Jans D.A. Nuclear transport of parathyroid hormone PTH-related protein is dependent on microtubules. Mol. Endocrinol. 16 (2002) 390-401
20. Lasmezas C.I., Deslys J.P., Robain O., Jaegly A., Beringue V., Peyrin J.M., Fournier J.G., Hauw J.J., Rossier J., and Dormont D. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275 (1997) 402-405
21. Lichota J., and Grasser K.D. Differential chromatin association and nucleosome binding of the maize HMGA, HMGB, and SSRP1 proteins. Biochemistry 40 (2001) 7860-7867
22. Lorenz H., Windl O., and Kretzschmar H.A. Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J. Biol. Chem. 277 (2002) 8508-8516
23. Ma J., and Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14955-14960
24. Ma J., Wollmann R., and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298 (2002) 1781-1785
25. Macara I.G. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65 (2001) 570-594 (table of contents)
26. Mange A., Crozet C., Lehmann S., and Beranger F. Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin. J. Cell Sci. 117 (2004) 2411-2416
27. Mattaj I.W., and Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 67 (1998) 265-306
28. Prusiner S.B., Scott M.R., Dearmond S.J., and Cohen F.E. Prion protein biology. Cell 93 (1998) 337-348
29. Roucou X., Guo Q., Zhang Y., Goodyer C.G., and LeBlanc A.C. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J. Biol. Chem. 278 (2003) 40877-40881
30. Solforosi L., Criado J.R., McGavern D.B., Wirz S., Sanchez-Alavez M., Sugama S., DeGiorgio L.A., Volpe B.T., Wiseman E., Abalos G., et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303 (2004) 1514-1516
31. Suntharalingam M., and Wente S.R. Peering through the pore: nuclear pore complex structure, assembly, and function. Dev. Cell 4 (2003) 775-789
32. Tatsumi Y., Tsurimoto T., Shirahige K., Yoshikawa H., and Obuse C. Association of human origin recognition complex 1 with chromatin DNA and nuclease-resistant nuclear structures. J. Biol. Chem. 275 (2000) 5904-5910
33. Vincent I., Pae C.I., and Hallows J.L. The cell cycle and human neurodegenerative disease. Prog. Cell Cycle Res. 5 (2003) 31-41
34. Yao M., Bain G., and Gottlieb D.I. Neuronal differentiation of P19 embryonal carcinoma cells in defined media. J. Neurosci. Res. 41 (1995) 792-804
35. Yedidia Y., Horonchik L., Tzaban S., Yanai A., and Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J. 20 (2001) 5383-5391